A FUNG SB - 130

Itraconazole Capsules 130 mg

(Supra-Bioavailable Formulation)

Capsules

Break the Cycle of Recalcitrant Fungal Infections

A Fung SB

Persistent Dermatophytosis is often associated with

Variable Absorption of Conventional Itraconazole

Inconsistant Plasma Concentrations

High Inter-Patient Variability

Suboptimal Drug Exposure...

A Fung SB 130 Advantage :

Enhanced Oral Absorption

Consistent Plasma Exposure

Reliable Pharmacokinetic Profile

Broad Spectrum Antifungal Activity..

Well Tolerated

A Supra Bioavailable Formulation Developed to Deliver Reliable Therapeutic Exposure and Support Improved Clinical Outcomes